PULMATRIX, INC. Investment Income, Interest
PULMATRIX, INC. (PULM) reported Investment Income, Interest of $10.00 thousand for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-09-17
- PULMATRIX, INC. investment income, interest for the quarter ending 2026-06-30 was $10.00K, a 75.61% decline year-over-year.
- PULMATRIX, INC. investment income, interest for the quarter ending 2026-03-31 was $12.00K, a 77.36% decline year-over-year.
- PULMATRIX, INC. investment income, interest for the quarter ending 2025-12-31 was $20.00K, a 72.60% decline year-over-year.
- PULMATRIX, INC. investment income, interest for the quarter ending 2025-09-30 was $30.00K, a 70.30% decline year-over-year.
- PULMATRIX, INC. investment income, interest for fiscal 2020 was $82.00K, a 72.76% decline from fiscal 2019.
- PULMATRIX, INC. investment income, interest for fiscal 2019 was $301.00K, a 1014.81% increase from fiscal 2018.
- PULMATRIX, INC. investment income, interest for fiscal 2018 was $27.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.00K S-4/A · filed 2026-09-17 | $22.00K S-4/A · filed 2026-09-17 | $42.00K derived: sum of 3 quarters · filed 2026-09-17 | $72.00K derived: sum of 4 quarters · filed 2026-09-17 |
| 2026-03-31 | $12.00K S-4/A · filed 2026-08-03 | $32.00K derived: sum of 2 quarters · filed 2026-09-17 | $62.00K derived: sum of 3 quarters · filed 2026-09-17 | $103.00K derived: sum of 4 quarters · filed 2026-09-17 |
| 2025-12-31 | $20.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $50.00K derived: sum of 2 quarters · filed 2026-09-17 | $91.00K derived: sum of 3 quarters · filed 2026-09-17 | $144.00K S-4/A · filed 2026-09-17 |
| 2025-09-30 | $30.00K 10-Q · filed 2025-10-16 | $71.00K derived: sum of 2 quarters · filed 2026-09-17 | $124.00K 10-Q · filed 2025-10-16 | $197.00K derived: sum of 4 quarters · filed 2026-09-17 |
| 2025-06-30 | $41.00K S-4/A · filed 2026-09-17 | $94.00K S-4/A · filed 2026-09-17 | $167.00K derived: sum of 3 quarters · filed 2026-09-17 | $268.00K derived: sum of 4 quarters · filed 2026-09-17 |
| 2025-03-31 | $53.00K S-4/A · filed 2026-08-03 | $126.00K derived: sum of 2 quarters · filed 2026-09-17 | $227.00K derived: sum of 3 quarters · filed 2026-09-17 | $360.00K derived: sum of 4 quarters · filed 2026-09-17 |
| 2024-12-31 | $73.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $174.00K derived: sum of 2 quarters · filed 2026-09-17 | $307.00K derived: sum of 3 quarters · filed 2026-09-17 | $467.00K S-4/A · filed 2026-09-17 |
| 2024-09-30 | $101.00K 10-Q · filed 2025-10-16 | $234.00K derived: sum of 2 quarters · filed 2025-10-16 | $394.00K 10-Q · filed 2025-10-16 | |
| 2024-06-30 | $133.00K 10-Q · filed 2025-08-06 | $293.00K 10-Q · filed 2025-08-06 | ||
| 2021-09-30 | $1.00K 10-Q · filed 2021-11-10 | $3.00K derived: sum of 2 quarters · filed 2021-11-10 | $6.00K 10-Q · filed 2021-11-10 | $10.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-10 | $5.00K 10-Q · filed 2021-08-10 | $9.00K derived: sum of 3 quarters · filed 2021-08-10 | $22.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-11 | $7.00K derived: sum of 2 quarters · filed 2021-05-11 | $20.00K derived: sum of 3 quarters · filed 2021-11-10 | $33.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $17.00K derived: sum of 2 quarters · filed 2021-11-10 | $30.00K derived: sum of 3 quarters · filed 2021-11-10 | $82.00K 10-K · filed 2021-03-23 |
| 2020-09-30 | $13.00K 10-Q · filed 2021-11-10 | $26.00K derived: sum of 2 quarters · filed 2021-11-10 | $78.00K 10-Q · filed 2021-11-10 | $152.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $13.00K 10-Q · filed 2021-08-10 | $65.00K 10-Q · filed 2021-08-10 | $139.00K derived: sum of 3 quarters · filed 2021-08-10 | $260.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-11 | $126.00K derived: sum of 2 quarters · filed 2021-05-11 | $247.00K derived: sum of 3 quarters · filed 2021-05-11 | $349.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $195.00K derived: sum of 2 quarters · filed 2021-03-23 | $297.00K derived: sum of 3 quarters · filed 2021-03-23 | $301.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $121.00K 10-Q · filed 2020-11-12 | $223.00K derived: sum of 2 quarters · filed 2020-11-12 | $227.00K 10-Q · filed 2020-11-12 | $231.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $102.00K 10-Q · filed 2020-08-07 | $106.00K 10-Q · filed 2020-08-07 | $110.00K derived: sum of 3 quarters · filed 2020-08-07 | $118.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $4.00K 10-Q · filed 2020-05-14 | $8.00K derived: sum of 2 quarters · filed 2020-05-14 | $16.00K derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $12.00K derived: sum of 2 quarters · filed 2020-03-26 | $27.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $8.00K 10-Q · filed 2019-11-01 | $23.00K 10-Q · filed 2019-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |